Vergoeding 2020-2024 voor ATC-subgroep R06AX : Overige antihistaminica voor systemisch gebruik
- Raming voor de totale Zvw-populatie
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| R06AX13 Loratadine (Hooikoortstablet loratadine htp ®) | 302.780 | 286.130 | 283.910 | 268.800 | 310.370 |
| R06AX17 Ketotifen (Zaditen ®) | 144.990 | 154.910 | 177.500 | 216.120 | 281.350 |
| R06AX18 Acrivastine (Semprex ®) | 198.600 | 201.550 | 182.040 | 166.820 | 165.760 |
| R06AX22 Ebastine (Kestine ®) | 274.590 | 250.480 | 255.500 | 224.760 | 231.120 |
| R06AX25 Mizolastine (Mizollen ®) | 578.930 | 572.320 | 565.320 | 556.340 | 534.930 |
| R06AX26 Fexofenadine (Telfast ®) | 1.814.400 | 1.950.000 | 2.683.400 | 2.646.400 | 2.701.700 |
| R06AX27 Desloratadine (Aerius ®) | 3.914.000 | 4.444.200 | 4.726.400 | 4.633.500 | 5.530.100 |
| R06AX28 Rupatadine (Rupafin ®) | 635.520 | 715.490 | 928.690 | 766.380 | 850.340 |
| Totaal | 7.863.810 | 8.575.080 | 9.802.760 | 9.479.120 | 10.605.670 |